University of Maryland Biotechnology Institute v. Presens Precision Sensing GmbH

711 F. App'x 1007
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 3, 2017
Docket2016-2745; 2017-1057
StatusUnpublished

This text of 711 F. App'x 1007 (University of Maryland Biotechnology Institute v. Presens Precision Sensing GmbH) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
University of Maryland Biotechnology Institute v. Presens Precision Sensing GmbH, 711 F. App'x 1007 (Fed. Cir. 2017).

Opinion

Lourie, Circuit Judge.

The University of Maryland Biotechnology Institute (“Maryland”) appeals from the inter partes reexamination decision of the United States Patent and Trademark Office (“PTO”) Patent Trial and Appeal Board (“the Board”) affirming the examiner’s rejection of claims 1, 3-6, 9-11, 13-16, 19, and 20 (“the claims”) of U.S. Patent 6,673,532 (“’532 patent”) as obvious under 35 U.S.C. § 103 (2006). 1 Presens Precision Sensing GmbH v. Univ. of Md. Biotechnology Inst., No. 2015-006297, 2015 WL 9581532 (P.T.A.B. Dec. 29, 2015) (“Decision”), reh’g denied, (P.T.A.B. July 29, 2016). Because the Board did not err in holding the claims invalid as obvious, we affirm.

Background

Maryland owns the ’532 patent, which covers methods of measuring parameters in cell culture. Cell culture is a widely used technique to cultivate cells in vitro. Parameters such as glucose, pH, and carbon dioxide and oxygen levels affect the viability of cell cultures. Consequently, monitoring such parameters is important in optimizing cell culture conditions. See, e.g., ’532 patent col. 111. 47-64.

The ’532 patent discloses an optical method of monitoring various cell culture parameters. The method implements four key components: (1) a cultivation vessel; (2) a sensor; (3) an excitation 1 source; and (4) a detector. Id. col. 5 11. 1-5. Cells are grown in a cultivation vessel that includes sensors which selectively bind to certain analytes. The sensors are light-sensitive, so when an excitation source such as a light-emitting diode (“LED”) shines on the sensors, the sensors emit light corresponding to the concentration of the relevant analytes. Detectors such as photomultiplier tubes then measure the light emitted by the sensors. Id. col. 4 l. 57-col. 5 l. 10.

Appellee Presens Precision Sensing (“Presens”) petitioned for inter partes reexamination of the ’532 patent, which the PTO granted. Claim 1 of the ’532 patent, as amended during reexamination, is representative and reads as follows:

1. A method of measuring at least two cultivation parameters in a cell culture, comprising:
(a) providing a cultivation vessel, wherein the cultivation vessel comprises, walls that define a single continuous volume or a non-planar surface that defines a single continuous volume, and at least two types of optical chemical sensors positioned within the single continuous volume;
(b) placing a continuous culture medium within the single continuous volume of the cultivation vessel such that the continuous culture medium is in contact with at least one of the walls that define the single continuous volume of the cultivation vessel or the non-planar surface that defines the single continuous volume of the cultivation vessel, wherein the optical chemical sensors are positioned such that they are in contact with the continuous culture medium;
(c) establishing a cell culture in the con-' tinuous culture medium;
(d) exciting the optical chemical sensors to generate emission and/or light absorption, wherein the optical chemical sensors are excited using at least one excitation source per optical chemical sensor;
(e) detecting the emission and/or absorption generated by the at least two optical chemical sensors in (d) by at least one detector for each type of optical chemical sensor used; and
(f) analyzing the detected emission and/or absorption detected in (c) to assess the at least two cultivation parameters measured.

J.A. 646-47,1005.

The examiner rejected the claims as, inter alia, obvious over Shabbir B. Bambot et al., Potential Applications of Lifetime-Based, Phase-Modulation Fluorimetry in Bioprocess and Clinical Monitoring, 13 Trends in Biotechnology 106 (1995) (“Bambot”), and Bernhard H. Weigl et al., Optical Triple Sensor for Measuring pH, Oxygen and Carbon Dioxide, 32 J. Biotechnology 127 (1994) (“Weigl”).

Bambot described optical methods of measuring analytes such as glucose, pH, and oxygen and carbon dioxide levels in bioreactors. The methods implemented the same set of components as the ’532 patent.

Various cultivation vessels housed sensors excitable by several types of excitation sources, and the sensors’ emissions could be measured by several different detectors.

Similarly, Weigl described a triple sensor device for measuring pH, oxygen, and carbon dioxide in a cultivation vessel. However, in Weigl the sensors were located in individual flow-through units outside the cultivation vessel. Each unit had a dedicated excitation source and detector. 'Given the teachings of Bambot and Weigl in combination, the examiner concluded that the claims of the ’532 patent would have been obvious over the references at the time the invention was made.

The Board affirmed the examiner’s obviousness rejection. The Board agreed that Bambot taught placing sensors inside a cultivation vessel, and also disclosed multiple types of sensors, detectprs, and excitation sources. Furthermore, the Board found that Weigl taught monitoring multiple parameters using a separate detector and excitation source for each type of sensor. Consequently, the Board concluded that “it would have been obvious to arrange more than one sensor inside a cultivation vessel and [use] the light excitation and detection means described in Bambot for each one.” Decision, 2015 WL 9581532, at *13.

Maryland appealed, and we have jurisdiction under 28 U.S.C. § 1295(a)(4)(A).

Discussion

Our review of a Board decision is limited. In re Baxter Int'l, Inc. 678 F.3d 1357, 1361 (Fed. Cir. 2012). We review the Board’s legal determinations de novo, In re Eisner, 381 F.3d 1125, 1127 (Fed. Cir. 2004), but we review the Board’s factual findings underlying those determinations for substantial evidence, In re Gartside, 203 F.3d 1305, 1316 (Fed. Cir. 2000). A finding is supported by substantial evidence if a reasonable mind might accept the evidence as adequate to support the finding. Consol. Edison Co. v. NLRB, 305 U.S. 197, 229, 59 S.Ct. 206, 83 L.Ed. 126 (1938).

The legal conclusion of obviousness turns on the familiar Graham factors, including the teachings of the prior art and the differences between those teachings and the claimed invention. Graham v. John Deere Co., 383 U.S, 1, 17-18, 86 S.Ct. 684, 15 L.Ed.2d 545 (1966).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Graham v. John Deere Co. of Kansas City
383 U.S. 1 (Supreme Court, 1966)
KSR International Co. v. Teleflex Inc.
550 U.S. 398 (Supreme Court, 2007)
In Re Daniel S. Fulton and James Huang
391 F.3d 1195 (Federal Circuit, 2004)
Application of Ferdinand J. Ratti
270 F.2d 810 (Customs and Patent Appeals, 1959)
In Re Lucas S. Gordon and Karl M. Sutherland
733 F.2d 900 (Federal Circuit, 1984)
In Re Berwyn E. Etter
756 F.2d 852 (Federal Circuit, 1985)
In Re Robert J. Gartside and Richard C. Norton
203 F.3d 1305 (Federal Circuit, 2000)
In Re Wilhelm Elsner. In Re Keith W. Zary
381 F.3d 1125 (Federal Circuit, 2004)
In Re Baxter International, Inc.
678 F.3d 1357 (Federal Circuit, 2012)
In Re Mouttet
686 F.3d 1322 (Federal Circuit, 2012)
In Re: Ethicon, Inc.
844 F.3d 1344 (Federal Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
711 F. App'x 1007, Counsel Stack Legal Research, https://law.counselstack.com/opinion/university-of-maryland-biotechnology-institute-v-presens-precision-sensing-cafc-2017.